Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 5/20 | 0.49 |
| ▸ | CA2 | P00918 | 5/20 | 0.49 |
| ▸ | CA12 | O43570 | 4/20 | 0.49 |
| ▸ | CA1 | P00915 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.38 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.34 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 0.34 |
| ▸ | P4HB | P07237 | 1/20 | 0.32 |
| ▸ | PDIA4 | P13667 | 1/20 | 0.32 |
| ▸ | PDIA3 | P30101 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7739748 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL13080340 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL7739258 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL7739256 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL13133631 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL12330761 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL332549 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL14038566 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL2441166 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 | |
| SCHEMBL332385 | 1.00 | OGA (0.50) | OGACA9CA2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110224422-A1 | PREPARATION OF CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224422-A1 | PREPARATION OF CAPECITABINE | DPYD, TYMP, DCTD | OGA 1849/4885CA9 1341/4885CA2 4653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.